Skip to content

Clinical trials

Phase 2 Febrile Neutropenia trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Febrile Neutropenia Phase: Phase 2 Country / region: China Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20132
20211
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Affiliated Hospital of Nantong University1
Jiangsu HengRui Medicine Co., Ltd.1
Qilu Pharmaceutical Co., Ltd.1
Shanghai Jiao Tong University School of Medicine1
The First Affiliated Hospital with Nanjing Medical University1
Tianjin Medical University Cancer Institute and Hospital1
Xiamen Amoytop Biotech Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Febrile Neutropenia7
Neutropenia4
Breast Neoplasms3
Carcinoma, Non-Small-Cell Lung2
Lung Neoplasms1
Thoracic Neoplasms1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.